This article announces that Amazon Omics has achieved FedRAMP Moderate authorization for AWS US regions.

• Amazon Omics now authorized for FedRAMP Moderate impact level workloads
• Authorization available in US East (N. Virginia) and US West (Oregon) regions
• Fully managed service for storing, querying, and analyzing genomic and omics data
• Enables healthcare and life science organizations to process regulated data at scale
• Removes infrastructure complexity for omics data analysis and insights generation

Amazon Omics can now be used for federal workloads requiring FedRAMP Moderate compliance in supported US regions.